Johnson & Johnson (JNJ) 106.50 $JNJ
The Next Stock Warren Buffett May Sell
Todd Campbell, Dan Caplinger, and George Budwell, The Motley Fool - Motley Fool - Sat Mar 05, 6:21AM CST
Warren Buffett is legendary for his long-term buy-and-hold approach to investing, and as a result, investors big and small closely watch his buying and selling activity. There's no crystal ball that will tell all of us what his next move will be, but...
JNJ: 106.50 (-0.15), LLY: 73.60 (+0.35), SNY: 39.81 (+0.19), VZ: 51.81 (-0.08)
Institutional Investors Bulk Up On Alphabet, Apple, Microsoft Stock
at Investor's Business Daily - Fri Mar 04, 5:17PM CST
The top five stocks held by institutional investors in the fourth quarter were Google parent Alphabet (GOOGL), Apple (AAPL), Microsoft (MSFT), JPMorgan Chase (JPM) and Johnson & Johnson (JNJ), CNBC said, citing eVestment data. The order for those...
JNJ: 106.50 (-0.15), HD: 125.56 (-1.24), JPM: 60.05 (+0.09), FB: 108.39 (-1.19), GOOGL: 730.22 (-1.37), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), CMCSA: 59.74 (-0.18), AAPL: 103.01 (+1.51)
Novo Nordisk Pops As Diabetes Drug Cuts Heart Disease Deaths
at Investor's Business Daily - Fri Mar 04, 3:26PM CST
Shares of diabetes giant Novo Nordisk (NVO) jumped Friday after the company said its drug Victoza reduced heart attacks and strokes. Novo released few details about the results of the study, which it's saving for the next American Diabetes...
JNJ: 106.50 (-0.15), NVO: 56.75 (+4.15), MRK: 52.08 (-0.02), AZN: 28.87 (+0.13), LLY: 73.60 (+0.35), SNY: 39.81 (+0.19)
Dow 30 Stock Roundup: Boeing Wins $276.3M Navy Contract, Cisco to Buy Cloud Startup for $260M
Swarup Gupta - Zacks Investment Research - Fri Mar 04, 2:52PM CST
The Dow continued to gain this week on the back of rising oil prices.
MMM: 160.07 (+0.69), ENDP: 42.44 (-0.73), GE: 30.46 (+0.24), XOM: 82.29 (-0.11), BA: 121.07 (+1.46), JNJ: 106.50 (-0.15), V: 73.90 (-0.01), ADP: 86.19 (+0.54), GS: 156.84 (+1.51), JPM: 60.05 (+0.09), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), BHI: 46.20 (-0.35)
3 Reasons Medivation, Inc. Stock Could Rise
Cory Renauer, The Motley Fool - Motley Fool - Fri Mar 04, 2:39PM CST
Along with the rest of the healthcare industry, Medivation stock has had a rough year, even despite a 10% pop following recently-announced strong fourth-quarter earnings. The boost was especially welcome after the beating Medivation has received...
MDVN: 40.44 (+2.24), JNJ: 106.50 (-0.15)
Drug Company Executives Make the Best Connections
at The Street - Fri Mar 04, 2:07PM CST
An analysis from business information service BoardEx shows that the CEOs of healthcare and pharma companies have professional networks about 30% larger than the average S&P 500 CEO network.
JNJ: 106.50 (-0.15), ABT: 39.18 (+0.36), IBM: 137.80 (unch), DGX: 69.32 (-0.39), LLY: 73.60 (+0.35), XRX: 10.50 (+0.10), ABBV: 56.15 (+0.22)
FDA clears new indication for AbbVie's blood cancer med IMBRUVICA
Seeking Alpha - at Seeking Alpha - Fri Mar 04, 12:27PM CST
JNJ: 106.50 (-0.15), ABBV: 56.15 (+0.22)
Finding 10% Yields Among The Dividend Champions
Eli Inkrot - at Seeking Alpha - Fri Mar 04, 11:56AM CST
KO: 44.11 (+0.15), JNJ: 106.50 (-0.15), ADM: 37.65 (+0.82), NUE: 42.96 (+0.21), PG: 83.49 (+0.65), BEN: 38.47 (+0.59)
Alphabet, Medtronic Among New Rivals For Intuitive Surgical
at Investor's Business Daily - Fri Mar 04, 11:13AM CST
California-based Intuitive Surgical (ISRG) got a boost last week when a new study showed that patients undergoing procedures with its da Vinci Surgical Systems experienced fewer complications than subjects undergoing conventional operations. That was...
ISRG: 570.65 (-3.39), JNJ: 106.50 (-0.15), MDT: 75.61 (+0.69), MZOR: 10.16 (+0.02), GOOGL: 730.22 (-1.37), TRXC: 3.53 (+0.33)
Altria Group Inc.: High Dividend, Fantastic Return
William Stamm - at Seeking Alpha - Fri Mar 04, 10:49AM CST
PM: 94.49 (+1.23), JNJ: 106.50 (-0.15), HD: 125.56 (-1.24), LB: 87.50 (+0.82), OHI: 33.29 (+0.12), MO: 62.98 (+0.75), BA: 121.07 (+1.46)
J&J, Pfizer, Merck, UnitedHealth -- Buy Them, Not the Health Care ETF
at The Street - Fri Mar 04, 7:13AM CST
These brand-name stocks are outperforming the exchange-traded fund.
JNJ: 106.50 (-0.15), UNH: 121.80 (-0.02), MRK: 52.08 (-0.02), PFE: 29.71 (-0.18), XLV: 67.41 (-0.16)
US stocks climb again as energy companies keep rising
By MARLEY JAY - AP - Thu Mar 03, 3:35PM CST
NEW YORK (AP) — Stocks made modest gains on Thursday as the market once again turned higher late in the day. Energy stocks led the way as investors continued to hope that oil prices have stabilized after almost two years of steep declines.
AGN: 288.67 (-0.95), ABT: 39.18 (+0.36), JNJ: 106.50 (-0.15), KR: 36.84 (-0.96), PFE: 29.71 (-0.18), COST: 150.90 (-0.70)
P&G Sells Hipoglos Diaper Rash Cream to Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 12:25PM CST
The Procter & Gamble Company (PG) announced that it has divested the Hipoglos diaper rash cream brand in Brazil to a subsidiary of healthcare company, Johnson & Johnson (JNJ).
JNJ: 106.50 (-0.15), COTY: 27.62 (-0.49), KMB: 132.54 (+0.91), PG: 83.49 (+0.65)
The Dividend Aristocrats: Real Time, Real World, Active Investing
David Crosetti - at Seeking Alpha - Thu Mar 03, 11:59AM CST
KO: 44.11 (+0.15), MMM: 160.07 (+0.69), JNJ: 106.50 (-0.15), KMB: 132.54 (+0.91), EMR: 51.26 (+0.47), LOW: 70.39 (+0.46), DOV: 63.20 (+0.75), PG: 83.49 (+0.65), CL: 68.16 (+0.55)
Dividends Don't Drive Total Return They Contribute To It: Part 1
Chuck Carnevale - Seeking Alpha - Thu Mar 03, 10:59AM CST
Introduction I believe there is a critical piece of investment wisdom that all investors in common stocks should possess. Every common stock investor should have a clear understanding of where and how long-term common stock returns are generated...
KO: 44.11 (+0.15), KMB: 132.54 (+0.91), VFC: 65.40 (-0.93), XOM: 82.29 (-0.11), SO: 48.63 (+0.44), PEP: 100.00 (+0.84), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), MCD: 117.18 (+0.49), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), SHW: 276.81 (+4.82), ECL: 106.33 (+1.09)
Is My Dividend Growth Experiment Working?
Chumpmenudo - at Seeking Alpha - Thu Mar 03, 10:57AM CST
KMI: 18.52 (-0.38), MDT: 75.61 (+0.69), DLR: 81.89 (-0.38), XOM: 82.29 (-0.11), TM: 109.55 (+0.98), O: 58.16 (-0.86), STAG: 18.85 (+0.04), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), ANTM: 132.35 (-0.62), JPM: 60.05 (+0.09), IBM: 137.80 (unch), BBL: 24.51 (+1.54), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), KO: 44.11 (+0.15), AMGN: 145.98 (+0.14), WFC: 50.11 (+0.34), MO: 62.98 (+0.75), SO: 48.63 (+0.44), TUP: 55.13 (+1.18), PM: 94.49 (+1.23), ADM: 37.65 (+0.82), OHI: 33.29 (+0.12), CVX: 87.93 (+0.40), AFL: 61.03 (+0.05)
Johnson & Johnson to Participate in Barclays Global Healthcare Conference
PR Newswire - Thu Mar 03, 10:00AM CST
Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference on Thursday, Mar. 17, at the Loews Miami Beach Hotel, Miami, FL. Dominic Caruso, Vice President, Finance & Chief Financial Officer and Ashley McEvoy, Company Group Chairman, Johnson & Johnson Diabetes Care Companies & Vision Care, Inc. will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).
JNJ: 106.50 (-0.15)
Are Dividend Payers About To Get Stingy?
Reuben Gregg Brewer - at Seeking Alpha - Thu Mar 03, 9:52AM CST
T: 37.93 (-0.06), JNJ: 106.50 (-0.15), WMT: 66.78 (+0.64), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32)
Intuitive Surgical Near Breakout As Study Shows Merits Of Da Vinci
at Investor's Business Daily - Thu Mar 03, 9:48AM CST
[video width="720" height="406" mp4="http://www.investors.com/wp-content/uploads/2016/03/030316_ISA_ISRG_SD.mp4"][/video] Results of a new study, announced Monday, showed patients undergoing procedures with the da Vinci robotic surgical systems from...
ISRG: 570.65 (-3.39), JNJ: 106.50 (-0.15), MDT: 75.61 (+0.69), FONR: 16.53 (-0.13), GOOGL: 730.22 (-1.37), CMN: 66.37 (+0.24)
Watch for Shares of Johnson & Johnson (JNJ) to Approach Support at $105.98
Comtex SmarTrend(R) - Thu Mar 03, 9:10AM CST
Shares of Johnson & Johnson (NYSE:JNJ) have bearishly opened below the pivot of $106.96 today and have reached the first support level of $106.51. Should the shares continue to fall, the support pivots of $105.98 and $105.00 will be of interest.
JNJ: 106.50 (-0.15)
The Next Stock Warren Buffett May Sell
Todd Campbell, Dan Caplinger, and George Budwell, The Motley Fool - Motley Fool - Sat Mar 05, 6:21AM CST
Warren Buffett is legendary for his long-term buy-and-hold approach to investing, and as a result, investors big and small closely watch his buying and selling activity. There's no crystal ball that will tell all of us what his next move will be, but...
JNJ: 106.50 (-0.15), LLY: 73.60 (+0.35), SNY: 39.81 (+0.19), VZ: 51.81 (-0.08)
Institutional Investors Bulk Up On Alphabet, Apple, Microsoft Stock
at Investor's Business Daily - Fri Mar 04, 5:17PM CST
The top five stocks held by institutional investors in the fourth quarter were Google parent Alphabet (GOOGL), Apple (AAPL), Microsoft (MSFT), JPMorgan Chase (JPM) and Johnson & Johnson (JNJ), CNBC said, citing eVestment data. The order for those...
JNJ: 106.50 (-0.15), HD: 125.56 (-1.24), JPM: 60.05 (+0.09), FB: 108.39 (-1.19), GOOGL: 730.22 (-1.37), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), CMCSA: 59.74 (-0.18), AAPL: 103.01 (+1.51)
Novo Nordisk Pops As Diabetes Drug Cuts Heart Disease Deaths
at Investor's Business Daily - Fri Mar 04, 3:26PM CST
Shares of diabetes giant Novo Nordisk (NVO) jumped Friday after the company said its drug Victoza reduced heart attacks and strokes. Novo released few details about the results of the study, which it's saving for the next American Diabetes...
JNJ: 106.50 (-0.15), NVO: 56.75 (+4.15), MRK: 52.08 (-0.02), AZN: 28.87 (+0.13), LLY: 73.60 (+0.35), SNY: 39.81 (+0.19)
Dow 30 Stock Roundup: Boeing Wins $276.3M Navy Contract, Cisco to Buy Cloud Startup for $260M
Swarup Gupta - Zacks Investment Research - Fri Mar 04, 2:52PM CST
The Dow continued to gain this week on the back of rising oil prices.
MMM: 160.07 (+0.69), ENDP: 42.44 (-0.73), GE: 30.46 (+0.24), XOM: 82.29 (-0.11), BA: 121.07 (+1.46), JNJ: 106.50 (-0.15), V: 73.90 (-0.01), ADP: 86.19 (+0.54), GS: 156.84 (+1.51), JPM: 60.05 (+0.09), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), BHI: 46.20 (-0.35)
3 Reasons Medivation, Inc. Stock Could Rise
Cory Renauer, The Motley Fool - Motley Fool - Fri Mar 04, 2:39PM CST
Along with the rest of the healthcare industry, Medivation stock has had a rough year, even despite a 10% pop following recently-announced strong fourth-quarter earnings. The boost was especially welcome after the beating Medivation has received...
MDVN: 40.44 (+2.24), JNJ: 106.50 (-0.15)
Drug Company Executives Make the Best Connections
at The Street - Fri Mar 04, 2:07PM CST
An analysis from business information service BoardEx shows that the CEOs of healthcare and pharma companies have professional networks about 30% larger than the average S&P 500 CEO network.
JNJ: 106.50 (-0.15), ABT: 39.18 (+0.36), IBM: 137.80 (unch), DGX: 69.32 (-0.39), LLY: 73.60 (+0.35), XRX: 10.50 (+0.10), ABBV: 56.15 (+0.22)
FDA clears new indication for AbbVie's blood cancer med IMBRUVICA
Seeking Alpha - at Seeking Alpha - Fri Mar 04, 12:27PM CST
JNJ: 106.50 (-0.15), ABBV: 56.15 (+0.22)
Finding 10% Yields Among The Dividend Champions
Eli Inkrot - at Seeking Alpha - Fri Mar 04, 11:56AM CST
KO: 44.11 (+0.15), JNJ: 106.50 (-0.15), ADM: 37.65 (+0.82), NUE: 42.96 (+0.21), PG: 83.49 (+0.65), BEN: 38.47 (+0.59)
Alphabet, Medtronic Among New Rivals For Intuitive Surgical
at Investor's Business Daily - Fri Mar 04, 11:13AM CST
California-based Intuitive Surgical (ISRG) got a boost last week when a new study showed that patients undergoing procedures with its da Vinci Surgical Systems experienced fewer complications than subjects undergoing conventional operations. That was...
ISRG: 570.65 (-3.39), JNJ: 106.50 (-0.15), MDT: 75.61 (+0.69), MZOR: 10.16 (+0.02), GOOGL: 730.22 (-1.37), TRXC: 3.53 (+0.33)
Altria Group Inc.: High Dividend, Fantastic Return
William Stamm - at Seeking Alpha - Fri Mar 04, 10:49AM CST
PM: 94.49 (+1.23), JNJ: 106.50 (-0.15), HD: 125.56 (-1.24), LB: 87.50 (+0.82), OHI: 33.29 (+0.12), MO: 62.98 (+0.75), BA: 121.07 (+1.46)
J&J, Pfizer, Merck, UnitedHealth -- Buy Them, Not the Health Care ETF
at The Street - Fri Mar 04, 7:13AM CST
These brand-name stocks are outperforming the exchange-traded fund.
JNJ: 106.50 (-0.15), UNH: 121.80 (-0.02), MRK: 52.08 (-0.02), PFE: 29.71 (-0.18), XLV: 67.41 (-0.16)
US stocks climb again as energy companies keep rising
By MARLEY JAY - AP - Thu Mar 03, 3:35PM CST
NEW YORK (AP) — Stocks made modest gains on Thursday as the market once again turned higher late in the day. Energy stocks led the way as investors continued to hope that oil prices have stabilized after almost two years of steep declines.
AGN: 288.67 (-0.95), ABT: 39.18 (+0.36), JNJ: 106.50 (-0.15), KR: 36.84 (-0.96), PFE: 29.71 (-0.18), COST: 150.90 (-0.70)
P&G Sells Hipoglos Diaper Rash Cream to Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 12:25PM CST
The Procter & Gamble Company (PG) announced that it has divested the Hipoglos diaper rash cream brand in Brazil to a subsidiary of healthcare company, Johnson & Johnson (JNJ).
JNJ: 106.50 (-0.15), COTY: 27.62 (-0.49), KMB: 132.54 (+0.91), PG: 83.49 (+0.65)
The Dividend Aristocrats: Real Time, Real World, Active Investing
David Crosetti - at Seeking Alpha - Thu Mar 03, 11:59AM CST
KO: 44.11 (+0.15), MMM: 160.07 (+0.69), JNJ: 106.50 (-0.15), KMB: 132.54 (+0.91), EMR: 51.26 (+0.47), LOW: 70.39 (+0.46), DOV: 63.20 (+0.75), PG: 83.49 (+0.65), CL: 68.16 (+0.55)
Dividends Don't Drive Total Return They Contribute To It: Part 1
Chuck Carnevale - Seeking Alpha - Thu Mar 03, 10:59AM CST
Introduction I believe there is a critical piece of investment wisdom that all investors in common stocks should possess. Every common stock investor should have a clear understanding of where and how long-term common stock returns are generated...
KO: 44.11 (+0.15), KMB: 132.54 (+0.91), VFC: 65.40 (-0.93), XOM: 82.29 (-0.11), SO: 48.63 (+0.44), PEP: 100.00 (+0.84), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), MCD: 117.18 (+0.49), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), SHW: 276.81 (+4.82), ECL: 106.33 (+1.09)
Is My Dividend Growth Experiment Working?
Chumpmenudo - at Seeking Alpha - Thu Mar 03, 10:57AM CST
KMI: 18.52 (-0.38), MDT: 75.61 (+0.69), DLR: 81.89 (-0.38), XOM: 82.29 (-0.11), TM: 109.55 (+0.98), O: 58.16 (-0.86), STAG: 18.85 (+0.04), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), ANTM: 132.35 (-0.62), JPM: 60.05 (+0.09), IBM: 137.80 (unch), BBL: 24.51 (+1.54), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), KO: 44.11 (+0.15), AMGN: 145.98 (+0.14), WFC: 50.11 (+0.34), MO: 62.98 (+0.75), SO: 48.63 (+0.44), TUP: 55.13 (+1.18), PM: 94.49 (+1.23), ADM: 37.65 (+0.82), OHI: 33.29 (+0.12), CVX: 87.93 (+0.40), AFL: 61.03 (+0.05)
Johnson & Johnson to Participate in Barclays Global Healthcare Conference
PR Newswire - Thu Mar 03, 10:00AM CST
Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference on Thursday, Mar. 17, at the Loews Miami Beach Hotel, Miami, FL. Dominic Caruso, Vice President, Finance & Chief Financial Officer and Ashley McEvoy, Company Group Chairman, Johnson & Johnson Diabetes Care Companies & Vision Care, Inc. will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).
JNJ: 106.50 (-0.15)
Are Dividend Payers About To Get Stingy?
Reuben Gregg Brewer - at Seeking Alpha - Thu Mar 03, 9:52AM CST
T: 37.93 (-0.06), JNJ: 106.50 (-0.15), WMT: 66.78 (+0.64), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32)
Intuitive Surgical Near Breakout As Study Shows Merits Of Da Vinci
at Investor's Business Daily - Thu Mar 03, 9:48AM CST
[video width="720" height="406" mp4="http://www.investors.com/wp-content/uploads/2016/03/030316_ISA_ISRG_SD.mp4"][/video] Results of a new study, announced Monday, showed patients undergoing procedures with the da Vinci robotic surgical systems from...
ISRG: 570.65 (-3.39), JNJ: 106.50 (-0.15), MDT: 75.61 (+0.69), FONR: 16.53 (-0.13), GOOGL: 730.22 (-1.37), CMN: 66.37 (+0.24)
Watch for Shares of Johnson & Johnson (JNJ) to Approach Support at $105.98
Comtex SmarTrend(R) - Thu Mar 03, 9:10AM CST
Shares of Johnson & Johnson (NYSE:JNJ) have bearishly opened below the pivot of $106.96 today and have reached the first support level of $106.51. Should the shares continue to fall, the support pivots of $105.98 and $105.00 will be of interest.
JNJ: 106.50 (-0.15)
